Xavier Becerra, President Joe Biden’s outgoing Health and Human Services secretary, is lamenting Americans’ abysmal distrust in federal health agencies while

BECERRA’S FINAL ACT — During the unveiling of his official portrait on Tuesday, HHS Secretary Xavier Becerra, who will soon depart the agency, highlighted the record number of people who have signed up for health insurance since he took the helm of the sprawling agency — and President Joe Biden’s role in it, Chelsea reports.

The Biden administration unveiled its list of 15 drugs, which include GLP-1 drugs, for the second annual round of drug price negotiations, made possible through the Inflation Reduction Act (IRA).

The Biden administration said a record 24.2 million Americans enrolled in individual coverage under the Affordable Care Act also known as Obamacare.

Sen. Ted Cruz supports Pam Bondi's confirmation as attorney general, calling her Trump's most crucial nominee and praising her strong hearing performance.

Biden’s secretary of health and human services defended him on Tuesday amid an open revolt within the Democratic Party over his ability to proceed as their nominee this fall.

In a wide-ranging interview, Xavier Becerra, President Biden’s health secretary, defended his tenure and hinted that he might run for governor of California.

President-elect Donald Trump will likely travel to California next week to view the aftermath of the devastating wildfires in greater Los Angeles.

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.

Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden administration said Friday.

The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule.

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.